Wellington Management Group LLP Denali Therapeutics Inc. Transaction History
Wellington Management Group LLP
- $503 Billion
- Q1 2025
A detailed history of Wellington Management Group LLP transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 11,409,598 shares of DNLI stock, worth $151 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,409,598Holding current value
$151 Million% of portfolio
0.03%Shares
11 transactions
Others Institutions Holding DNLI
# of Institutions
231Shares Held
128MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$174 Million0.01% of portfolio
-
Baillie Gifford & CO12MShares$158 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$156 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$89.5 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$70.8 Million0.37% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.77B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...